Associate Vice President for Research and Professor of Biology at UT Arlington
Dr. Weidanz is currently Associate Vice President for Research and Professor of Biology at UT Arlington. Dr. Weidanz Co-founded Abexxa Biologics in 2015 to develop breakthrough immunotherapeutics to revolutionize cancer treatments by providing highly effective targeted therapies. Dr. Weidanz previously was a University Distinguished Professor at the School of Pharmacy at Texas Tech University Health Sciences Center (TTUHSC) and Chairman of the Department of Immunotherapeutics and Biotechnology, which he founded in 2012.
Dr. Weidanz has over 25 years-experience in the field of cancer immunotherapy, with particular knowledge in the area of HLA-peptide biology and development of TCR-like antibody therapeutics.
The North Texas Genome Center represents a collaborative venture between multiple universities, medical centers, and corporate partners to establish a center of excellence for genomics and high throughput sequencing. Housed at the University of Texas at Arlington, in the center of the Dallas-Ft. Worth Metroplex, the North Texas Genome Center utilizes a core of five Illumina […]